Search

Your search keyword '"Shih, David Q."' showing total 27 results

Search Constraints

Start Over You searched for: Author "Shih, David Q." Remove constraint Author: "Shih, David Q." Topic inflammatory bowel diseases Remove constraint Topic: inflammatory bowel diseases
27 results on '"Shih, David Q."'

Search Results

1. Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists.

2. Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease.

3. Insights on the use of biosimilars in the treatment of inflammatory bowel disease.

4. Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway.

5. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.

6. Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel Disease.

7. Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.

8. Immunopathology of inflammatory bowel disease.

9. Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.

10. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis.

11. Insights into TL1A and IBD pathogenesis.

12. Insights into IBD Pathogenesis.

13. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells.

14. Recent advances in IBD pathogenesis: genetics and immunobiology.

15. Immunopathogenesis of inflammatory bowel disease.

16. Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome.

17. CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway

18. Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis.

19. High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures.

20. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.

21. Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1.

22. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.

23. Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice.

24. Cathelicidin Signaling via the Toll-like Receptor Protects Against Colitis in Mice.

25. The protection role of Atg16l1 in CD11c+dendritic cells in murine colitis.

26. TL1A primed dendritic cells activation exacerbated chronic murine colitis.

27. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.

Catalog

Books, media, physical & digital resources